Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality, with limited treatment options at advanced stages. The gut microbiota, a diverse community of microorganisms residing in the gastrointestinal tract, plays a pivotal role in regulating immune responses through the gut...
Saved in:
| Main Authors: | Mingyao Huang, Quansong Ji, Huiyan Huang, Xiaoqian Wang, Lin Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Gut Microbes |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2025.2486519 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiota reshapes the TNBC immune microenvironment: Emerging immunotherapeutic strategies
by: Mingyao Huang, et al.
Published: (2025-05-01) -
HCC and Immunotherapy: The Potential Predictive Role of Gut Microbiota and Future Therapeutic Strategies
by: Carmelo Laface, et al.
Published: (2025-02-01) -
Gut Microbiota and Alzheimer Disease
by: Lester Raymundo Dominguez Huarcaya
Published: (2025-01-01) -
The role of the gut microbiota in shaping the tumor microenvironment and immunotherapy of breast cancer
by: Xiaoying Ren, et al.
Published: (2025-05-01) -
Modulation of gut microbiota by probiotics to improve the efficacy of immunotherapy in hepatocellular carcinoma
by: Ping Chen, et al.
Published: (2024-11-01)